Atlas Trials

Clinical Efficacy of MOAP Regimen for Relapsed/Refractory cHL as a Rescue Therapy After DP Regimen

Clinical trial NCT04026269 · UNKNOWN

Trial details

NCT number
NCT04026269
Sponsor
Han weidong
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hodgkin Lymphoma
Start date
2019-07-30
Primary completion
2020-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.